![Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet](https://www.thelancet.com/cms/asset/04f3d1bc-8493-4bfa-9572-fc2f5606352f/gr1.jpg)
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet
![Electrocorticographic evidence of a common neurocognitive sequence for mentalizing about the self and others | Nature Communications Electrocorticographic evidence of a common neurocognitive sequence for mentalizing about the self and others | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-29510-2/MediaObjects/41467_2022_29510_Fig1_HTML.png)
Electrocorticographic evidence of a common neurocognitive sequence for mentalizing about the self and others | Nature Communications
![Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults | Nature Microbiology Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults | Nature Microbiology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41564-022-01237-2/MediaObjects/41564_2022_1237_Fig1_HTML.png)
Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults | Nature Microbiology
![Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries - The Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries - The](https://www.thelancet.com/cms/asset/e46c2cf8-3043-46d9-846e-5bd33717f1fe/gr1.jpg)
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries - The
![The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA | Nature Communications The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-021-21953-3/MediaObjects/41467_2021_21953_Fig1_HTML.png)
The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA | Nature Communications
![Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study - The Lancet ... Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study - The Lancet ...](https://www.thelancet.com/cms/asset/eff521c8-8eef-4742-84fa-adb3df91181b/gr1.jpg)
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study - The Lancet ...
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis | PLOS Medicine
![Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses - The Lancet Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses - The Lancet](https://www.thelancet.com/cms/attachment/4e975ca1-4009-4d5c-b0cf-91de24db7b95/gr1.jpg)
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses - The Lancet
![Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses - The Lancet Digital Health Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses - The Lancet Digital Health](https://www.thelancet.com/cms/asset/d2255361-20a1-4ac2-930e-d67ce26ad8cd/gr1.jpg)